SCHEMBL6217014

SCHEMBL6217014

[CH2]S(=O)(=O)c1ccsc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3272540 0.79 HTR6 (0.39)
Ethylene SCHEMBL27589672 0.76 TSHR (0.41)
SCHEMBL1035591 0.75
SCHEMBL11387848 0.75 L3MBTL1 (0.36)
SCHEMBL354012 0.75
Hydrochloric Acid SCHEMBL27394711 0.73 TSHR (0.42)
SCHEMBL27742303 0.73 CA2 (0.42)
SCHEMBL5559191 0.73 ALDH1A1 (0.42)
Lithium Ion SCHEMBL22394574 0.73 LMNA (0.35)
SCHEMBL9424788 0.73 LMNA (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1575947-A1 2-OXOPYRIDIN-3-YL THIA(DI)AZOLE DERIVATIVES FOR USE IN THE TREATMENT OF CELL PROLIFERATION AND APOPTOSIS RELATED DISEASES Amgen Inc. (US) 2005-09-21 EP claimed
US-20040147561-A1 Pyrid-2-one derivatives and methods of use SYNGENTA CROP PROTECTION AG (CH) 2004-07-29 US claimed
WO-2004060890-A1 2-OXOPYRIDIN-3-YL THIA (DI) AZOLE DERIVATES FOR USE IN THE TREATMENT OF CELL PROLIFERATION AND APOPTOSIS RELATED DISEASES AMGEN INC. (US) 2004-07-22 WO claimed